VNV Global Marks Vezeeta Down, Implies $26M Value

In Short

• VNV Global reduced the carrying value of its Vezeeta stake by 13% to $2.3 million in the first half of 2026.
• With VNV reporting 9% ownership, the mark implies an approximate Vezeeta valuation of $26 million.
• The update is part of VNV’s broader portfolio revaluation across private MENA and Africa tech holdings.

What Happened

VNV Global’s first-half 2026 accounts give a window into how it is valuing private companies in its MENA and Africa portfolio. One of the clearest signals is the write-down in Vezeeta, the Egypt-founded healthcare booking and services company.

VNV marked its Vezeeta holding down 13% to $2.3 million. VNV says it owns 9% of the business. On a simple pro-rata basis, that implies a company valuation of about $26 million.

These figures are not a new announced funding-round valuation from Vezeeta. They are derived from VNV’s reported ownership percentage and the value it assigns to its stake on its balance sheet.

VNV’s accounts also show mixed moves across other regional investments. It kept its Breadfast stake flat, marked Baly higher using an internal model, and wrote down other positions including the merged Wasoko and MaxAB business.

Why It Matters

Public-market investors like VNV have to publish portfolio marks, meaning updated estimates of what their private holdings are worth. These marks can act as a proxy for private market pricing, even when startups are not raising new rounds.

For operators and investors tracking Health Tech in Africa and MENA, the implied Vezeeta valuation highlights how far late-stage pricing can compress during slower fundraising cycles. It also shows why portfolio reporting is becoming a key source of pricing signals, alongside announced rounds and secondary share sales.